Lv1
8 积分 2024-09-12 加入
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
7小时前
已完结
Comparison between intravitreal brolucizumab and aflibercept in the treatment-naive central involved diabetic macular edema: One-year real-life case series
7小时前
已完结
Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study
7小时前
已完结
Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability
8小时前
已完结
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies
1个月前
已关闭
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
2个月前
已完结
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
2个月前
已完结
Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation
3个月前
已完结
Analysis of CRSsNP Proteome Using a Highly Multiplexed Approach in Nasal Mucus
3个月前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
4个月前
已完结
皖公网安备34019202002308
